Skip to main content
. 2017 Apr 7;8(34):56311–56326. doi: 10.18632/oncotarget.16910

Figure 4. Biodistribution of CD70-TTC in the subcutaneous 786-O xenograft model.

Figure 4

Biodistribution of CD70-TTC and an isotype control-TTC was analyzed 7 days after single i.v. administration of each compound at a dose of 500 kBq/kg (protein dose of 0.36 mg/kg). (A) Accumulation of 227Th expressed in % of injected dose per gram, decay corrected to the timepoint of injection in tumors and organs. (B–C) Accumulation of 227Th (Bq/g) and 223Ra (Bq/g), decay corrected to timepoint of euthanization in tumors and organs.